BZAM (OTCMKTS:BZAMF – Get Free Report) is one of 250 public companies in the “Drug Manufacturers – Specialty & Generic” industry, but how does it weigh in compared to its competitors? We will compare BZAM to similar companies based on the strength of its dividends, profitability, institutional ownership, analyst recommendations, risk, earnings and valuation. Institutional […]